Caveolin-1 interacts with alpha-synuclein and mediates toxic actions of cellular alpha-synuclein overexpression

Neurochemistry International

Volumn 59, Issue 2, 2011, Pages 280-289

  Madeira, Alexandra ^a   Yang, Junfeng ^a   Zhang, Xiaoqun ^a   Vikeved, Elisabet ^a   Nilsson, Anna ^b   Andrén, Per E ^b   Svenningsson, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cell death; Lipid rafts; N2A; Neurotoxicity; Parkinson; Proteasome inhibitor

Indexed keywords

ALPHA SYNUCLEIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BRAIN EXTRACT; CAVEOLIN 1; COMPACTIN; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; GENE OVEREXPRESSION; GENE SILENCING; MASS SPECTROMETRY; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE;

ALPHA-SYNUCLEIN; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CAVEOLIN 1; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; PROTEIN BINDING; RNA, SMALL INTERFERING; SURFACE PLASMON RESONANCE;

EID: 79960351124     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.05.017     Document Type: Article

References (40)

1. C. Aisenbrey, T. Borowik, R. Bystrom, M. Bokvist, F. Lindstrom, H. Misiak, M.A. Sani, and G. Grobner How is protein aggregation in amyloidogenic diseases modulated by biological membranes? Eur. Biophys. J. 37 2008 247 255
2. E.E. Benarroch Lipid rafts, protein scaffolds, and neurologic disease Neurology 69 2007 1635 1639 (Pubitemid 350287148)
3. M.C. Bennett, J.F. Bishop, Y. Leng, P.B. Chock, T.N. Chase, and M.M. Mouradian Degradation of alpha-synuclein by proteasome J. Biol. Chem. 274 1999 33855 33858
4. Brueggemann N.; Odin P.; Gruenewald A.; Tadic V.; Hagenah J.; Seidel G.; Lohmann K.; Klein C. and Djarmati A. (2008) Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease. Neurology 71, 1294; author reply 1294.
5. R. Chakravarti, and V. Sahai Compactin - a review Appl. Microbiol. Biotechnol. 64 2004 618 624 (Pubitemid 38822624)
6. M.R. Cookson Alpha-synuclein and neuronal cell death Mol. Neurodegeneration 4 2009 9
7. L. Devi, V. Raghavendran, B.M. Prabhu, N.G. Avadhani, and H.K. Anandatheerthavarada Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain J. Biol. Chem. 283 2008 9089 9100
8. M. Dyllick-Brenzinger, C.A. D'Souza, B. Dahlmann, P.M. Kloetzel, and A. Tandon Reciprocal effects of alpha-synuclein overexpression and proteasome inhibition in neuronal cells and tissue Neurotox. Res. 17 2010 215 227
9. L.S. Forno Neuropathology of Parkinson's disease J. Neuropathol. Exp. Neurol. 55 1996 259 272 (Pubitemid 26085575)
10. D.L. Fortin, M.D. Troyer, K. Nakamura, S. Kubo, M.D. Anthony, and R.H. Edwards Lipid rafts mediate the synaptic localization of alpha-synuclein J. Neurosci. 24 2004 6715 6723 (Pubitemid 38993891)
11. D.J. Gelb, E. Oliver, and S. Gilman Diagnostic criteria for Parkinson disease Arch. Neurol. 56 1999 33 39 (Pubitemid 29046907)
12. M. Goedert Alpha-synuclein and neurodegenerative diseases Nat. Rev. 2 2001 492 501 (Pubitemid 33676584)
13. D.G. Graham, S.M. Tiffany, W.R. Bell, and W.F. Gutknecht Jr. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro Mol. Pharmacol. 14 1978 644 653 (Pubitemid 8402470)
14. M.F. Hanzal-Bayer, and J.F. Hancock Lipid rafts and membrane traffic FEBS Lett. 581 2007 2098 2104 (Pubitemid 46709907)
15. M. Hashimoto, T. Takenouchi, E. Rockenstein, and E. Masliah Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease J. Neurochem. 85 2003 1468 1479 (Pubitemid 36702559)
16. L.J. Hsu, Y. Sagara, A. Arroyo, E. Rockenstein, A. Sisk, M. Mallory, J. Wong, T. Takenouchi, M. Hashimoto, and E. Masliah Alpha-synuclein promotes mitochondrial deficit and oxidative stress Am. J. Pathol. 157 2000 401 410 (Pubitemid 30627559)
17. M. Ihara, N. Yamasaki, A. Hagiwara, A. Tanigaki, A. Kitano, R. Hikawa, H. Tomimoto, M. Noda, M. Takanashi, H. Mori, N. Hattori, T. Miyakawa, and M. Kinoshita Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity Neuron 53 2007 519 533 (Pubitemid 46216751)
18. T. Ikeuchi, A. Kakita, A. Shiga, K. Kasuga, H. Kaneko, C.F. Tan, J. Idezuka, K. Wakabayashi, O. Onodera, T. Iwatsubo, M. Nishizawa, H. Takahashi, and A. Ishikawa Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia Arch. Neurol. 65 2008 514 519 (Pubitemid 351549961)
19. K.A. Jellinger Recent advances in our understanding of neurodegeneration J. Neural. Transm. 116 2009 1111 1162
20. M. Kim, W. Jung, I.H. Lee, G. Bhak, S.R. Paik, and J.S. Hahn Impairment of microtubule system increases alpha-synuclein aggregation and toxicity Biochem. Biophys. Res. Commun. 365 2008 628 635 (Pubitemid 350234838)
21. W.W. Li, R. Yang, J.C. Guo, H.M. Ren, X.L. Zha, J.S. Cheng, and D.F. Cai Localization of alpha-synuclein to mitochondria within midbrain of mice Neuroreport 18 2007 1543 1546 (Pubitemid 47476380)
22. A. Madeira, E. Ohman, A. Nilsson, B. Sjogren, P.E. Andren, and P. Svenningsson Coupling surface plasmon resonance to mass spectrometry to discover novel protein-protein interactions Nat. Protoc. 4 2009 1023 1037
23. K.S. McNaught, and P. Jenner Proteasomal function is impaired in substantia nigra in Parkinson's disease Neurosci. Lett. 297 2001 191 194 (Pubitemid 32011306)
24. A. Moszczynska, J. Saleh, H. Zhang, B. Vukusic, F.J. Lee, and F. Liu Parkin disrupts the alpha-synuclein/dopamine transporter interaction: consequences toward dopamine-induced toxicity J. Mol. Neurosci. 32 2007 217 227 (Pubitemid 47574970)
25. K. Nakamura, V.M. Nemani, E.K. Wallender, K. Kaehlcke, M. Ott, and R.H. Edwards Optical reporters for the conformation of alpha-synuclein reveal a specific interaction with mitochondria J. Neurosci. 28 2008 12305 12317
26. E. Ohman, A. Nilsson, A. Madeira, B. Sjogren, P.E. Andren, and P. Svenningsson Use of surface plasmon resonance coupled with mass spectrometry reveals an interaction between the voltage-gated sodium channel type X alpha-subunit and caveolin-1 J. Proteome Res. 7 2008 5333 5338
27. M. Orth, S.J. Tabrizi, A.H. Schapira, and J.M. Cooper Alpha-synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone Neurosci. Lett. 351 2003 29 32 (Pubitemid 37205177)
28. E. Paxinou, Q. Chen, M. Weisse, B.I. Giasson, E.H. Norris, S.M. Rueter, J.Q. Trojanowski, V.M. Lee, and H. Ischiropoulos Induction of alpha-synuclein aggregation by intracellular nitrative insult J. Neurosci. 21 2001 8053 8061 (Pubitemid 32952762)
29. L. Petrucelli, C. O'Farrell, P.J. Lockhart, M. Baptista, K. Kehoe, L. Vink, P. Choi, B. Wolozin, M. Farrer, J. Hardy, and M.R. Cookson Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons Neuron 36 2002 1007 1019 (Pubitemid 36044504)
30. A.F. Quest, L. Leyton, and M. Parraga Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease Biochem. Cell Biol. = Biochim. Baiol. Cellulaire 82 2004 129 144 (Pubitemid 38580879)
31. A. Recchia, P. Debetto, A. Negro, D. Guidolin, S.D. Skaper, and P. Giusti Alpha-synuclein and Parkinson's disease Faseb J. 18 2004 617 626
32. B. Sjogren, and P. Svenningsson Caveolin-1 affects serotonin binding and cell surface levels of human 5-HT7(a) receptors FEBS Lett. 581 2007 5115 5121 (Pubitemid 47576096)
33. W.W. Smith, H. Jiang, Z. Pei, Y. Tanaka, H. Morita, A. Sawa, V.L. Dawson, T.M. Dawson, and C.A. Ross Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity Hum. Mol. Genet. 14 2005 3801 3811 (Pubitemid 43020082)
34. E. Spisni, V. Tomasi, A. Cestaro, and S.C. Tosatto Structural insights into the function of human caveolin 1 Biochem. Biophys. Res. Commun. 338 2005 1383 1390 (Pubitemid 41608405)
35. N. Sunaga, K. Miyajima, M. Suzuki, M. Sato, M.A. White, R.D. Ramirez, J.W. Shay, A.F. Gazdar, and J.D. Minna Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer Cancer Res. 64 2004 4277 4285 (Pubitemid 38802434)
36. Y. Tanaka, S. Engelender, S. Igarashi, R.K. Rao, T. Wanner, R.E. Tanzi, A. Sawa, T.M. Dawson, and C.A. Ross Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis Hum. Mol. Genet. 10 2001 919 926 (Pubitemid 32401408)
37. Troiano A. R.; Cazeneuve C.; Le Ber I.; Bonnet A. M.; Lesage S. and Brice A.; 2008. Re: Alpha-synuclein gene duplication is present in sporadic Parkinson disease. Neurology 71, 1295; author reply 1295.
38. R. Ved, S. Saha, B. Westlund, C. Perier, L. Burnam, A. Sluder, M. Hoener, C.M. Rodrigues, A. Alfonso, C. Steer, L. Liu, S. Przedborski, and B. Wolozin Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans J. Biol. Chem. 280 2005 42655 42668 (Pubitemid 43049224)
39. Z.F. Wang, J. Yin, Y. Zhang, L.Q. Zhu, Q. Tian, X.C. Wang, H.L. Li, and J.Z. Wang Overexpression of tau proteins antagonizes amyloid-beta-potentiated apoptosis through mitochondria-caspase-3 pathway in N2a cells J. Alzheimers Dis. 2010
40. Z. Zhou, S. Kerk, and T. Meng Lim Endogenous dopamine (DA) renders dopaminergic cells vulnerable to challenge of proteasome inhibitor MG132 Free Radic. Res. 42 2008 456 466 (Pubitemid 351935159)